Table of Content - Recombinant Dna Technology Market

Global recombinant DNA technology market is estimated to be valued at USD 172.94 Bn in 2024 and is expected to exhibit a CAGR of 9.6% during the forecast period (2024-2031). Recombinant DNA technology is the joining together of DNA molecules from two different sources into one molecule that can replicate and direct the assembly of its own components or related proteins. This process involves physically combining and interweaving two different strands of DNA through the use of restriction enzymes, DNA ligases and reverse transcriptase. In recent years, recombinant DNA technology has proven to be a revolutionary advancement in the field of genetics and biotechnology with wide ranging applications in drug development, research, and agriculture. This technology allows for the production of human proteins and medicines in much larger quantities than traditional extraction methods. It is also being used to develop new treatments for currently incurable diseases and to enhance crop yields. With growing demand across industries, the recombinant DNA technology market is poised to grow significantly in the coming years.

Market Dynamics:

The recombinant DNA technology market is driven by several factors such as increasing R&D activities in pharmaceutical and biotech industries, rising prevalence of chronic diseases, growing demand for genetic engineering, and gene therapy. The demand for affordable healthcare and therapeutic solutions combined with technological advancements in DNA analysis and sequencing techniques are also fueling the market growth. However, the market growth can be restricted due to high costs associated with development and stringent regulations for clinical trials. Moreover, ethical issues regarding germline gene editing may hamper market expansion to some extent. On the flip side, rising healthcare expenditures in emerging nations offer lucrative opportunities for key players. In addition, the growing acceptance of genetically modified crops for agriculture applications is expected to create new revenue pockets in the forthcoming years.

Key Features of the Study:

This report provides an in-depth analysis of the global recombinant DNA technology market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global recombinant DNA technology market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Thermo Fisher Scientific, Inc., Biogen, Inc., Sanofi , Pfizer, Inc., Amgen, Inc., Merck & Co., Inc., Profacgen, Monsanto Company, Genentech Inc., Eli Lilly and Company, Janssen Pharmaceuticals Inc., GSK plc., Jiangsu Recbio Technology Co., Ltd., New England Biolabs, GenScript, Lonza, and ProteoGenix.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global recombinant DNA technology market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global recombinant DNA technology market.

Detailed Segmentation-

By Product Type:
- Recombinant Protein Drugs
- Vaccines
- Genetically Modified Crops
- Cell and Gene Therapy
- Gene Editing
By Application:
- Therapeutics
- Agriculture
- Research
- Others
By End User:
- Biotechnology and Pharmaceutical Company
- Diagnostic Laboratories
- Academic and Government Laboratories
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa

Company Profiles:

Thermo Fisher Scientific, Inc.
Biogen, Inc.
Sanofi
Pfizer, Inc.
Amgen, Inc.
Merck & Co., Inc.
Profacgen
Monsanto Company
Genentech Inc.
Eli Lilly and Company
Janssen Pharmaceuticals Inc.
GSK plc.
Jiangsu Recbio Technology Co., Ltd.
New England Biolabs
GenScript
Lonza
ProteoGenix

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Product Type
  - Market Snapshot, By Application
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Regulatory Scenario
- Technological Advancements
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
Global Recombinant DNA Technology Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
Global Recombinant DNA Technology Market, By Product Type, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Recombinant Protein Drugs
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Vaccines
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Genetically Modified Crops
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Cell and Gene Therapy
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Gene Editing
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Recombinant DNA Technology Market, By Application, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Therapeutics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Agriculture
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Research
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Recombinant DNA Technology Market, By End User, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Biotechnology and Pharmaceutical Company
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Diagnostic Laboratories
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Academic and Government Laboratories
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Recombinant DNA Technology Market, By Region, 2019 – 2031, (USD Bn)
- Introduction
  - Market Share Analysis, By Region, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, For Region, 2019–2031
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Thermo Fisher Scientific, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Biogen, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Sanofi
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Pfizer, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Amgen, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Merck & Co., Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Profacgen
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Monsanto Company
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Genentech Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Eli Lilly and Company
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Janssen Pharmaceuticals Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - GSK plc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Jiangsu Recbio Technology Co., Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - New England Biolabs
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - GenScript
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Lonza
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - ProteoGenix
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

*Browse 38 market data tables and 31 figures on "Recombinant DNA Technology Market” - Global forecast to 2031

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount